I would estimate a price range of $2.50 to $3.20 if the first Phase 3 trial is announced as successful. That’s just 220 more sleeps away!
At least $5 if both trials are successful and the drug is submitted for regulatory approval with FDA and Europe.$2.50 a share is really exciting. But a 40 PE? That would be off the charts! A crazy as it sounds 40PE isn't crazy, as you say CSL as a ASX Top5 stock and as you say PE of 37 proves the point.
With that kind of fairy tale ending, in 2026 FFS family may never have to fly commercial again.
Ann: Security Class Reinstatement to Quotation- OPTOB, page-211
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
59.5¢ |
Change
-0.015(2.46%) |
Mkt cap ! $732.5M | |||
| Open | High | Low | Value | Volume |
| 60.0¢ | 61.0¢ | 59.0¢ | $11.30M | 18.98M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 45916 | 59.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 60.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
| OPT (ASX) Chart |